Pluribus Labs’s Molina Healthcare MOH Stock Holding History

Pluribus Labs’s Portfolio MOH Stock Details MOH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,548	Closed	-$492K	–	167
2021 Q4	$492K	Buy	+1,548	New	+$460K	0.52%	51

Other funds holding MOH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pluribus Labs's MOH Position: Q1 2022 in Review

Pluribus Labs sold out of Molina Healthcare (MOH) in Q1 2022, closing a stake of 1,548 shares — an estimated $492K sold.

Pluribus Labs first reported a position in MOH in Q4 2021 and held it in 1 quarter. The position peaked at $492K in Q4 2021. 529 funds tracked by Wall St. Rank hold MOH as of Q1 2022.

Pluribus Labs reported no remaining Molina Healthcare position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 1,548 Molina Healthcare shares in Q1 2022, an estimated $492K.
Pluribus Labs first reported a position in Molina Healthcare in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Molina Healthcare position peaked at $492K in Q4 2021.
529 funds tracked by Wall St. Rank held Molina Healthcare as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.